MCM
ZYME icon

Marathon Capital Management’s Zymeworks ZYME Stock Holding History

Marathon Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,250
Closed -$210K – 164
2023
Q4 		$210K Hold
20,250
– – 0.05% 133
2023
Q3 		$128K Sell
20,250
-5,000
-20% -$36.9K 0.03% 144
2023
Q2 		$218K Sell
25,250
-1,000
-4% -$8.95K 0.05% 139
2023
Q1 		$237K Buy
+26,250
New +$229K 0.06% 138
2022
Q4 		– Sell
-27,250
Closed -$168K – 153
2022
Q3 		$168K Hold
27,250
– – 0.05% 140
2022
Q2 		$144K Sell
27,250
-20,590
-43% -$125K 0.05% 137
2022
Q1 		$313K Buy
47,840
+3,500
+8% +$31.2K 0.09% 80
2021
Q4 		$727K Sell
44,340
-2,125
-5% -$44.3K 0.17% 84
2021
Q3 		$1.35M Buy
46,465
+630
+1% +$20.9K 0.31% 56
2021
Q2 		$1.59M Buy
45,835
+250
+0.5% +$7.93K 0.37% 51
2021
Q1 		$1.44M Buy
45,585
+6,200
+16% +$252K 0.38% 46
2020
Q4 		$1.86M Sell
39,385
-6,650
-14% -$309K 0.55% 39
2020
Q3 		$2.14M Sell
46,035
-1,625
-3% -$55.8K 0.78% 27
2020
Q2 		$1.72M Sell
47,660
-1,000
-2% -$36.8K 0.66% 27
2020
Q1 		$1.73M Sell
48,660
-650
-1% -$26.6K 0.79% 19
2019
Q4 		$2.24M Sell
49,310
-3,125
-6% -$114K 0.76% 23
2019
Q3 		$1.3M Buy
52,435
+260
+0.5% +$6.51K 0.52% 31
2019
Q2 		$1.15M Buy
+52,175
New +$958K 0.47% 35

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Marathon Capital Management's ZYME Position: Q1 2024 in Review

Marathon Capital Management sold out of Zymeworks (ZYME) in Q1 2024, closing a stake of 20,250 shares — an estimated $210K sold.

Marathon Capital Management first reported a position in ZYME in Q2 2019 and held it in 18 quarters. The position peaked at $2.24M in Q4 2019. 171 funds tracked by Wall St. Rank hold ZYME as of Q1 2024.

  • Marathon Capital Management reported no remaining Zymeworks position as of Q1 2024 after selling out during the quarter.
  • Marathon Capital Management sold 20,250 Zymeworks shares in Q1 2024, an estimated $210K.
  • Marathon Capital Management first reported a position in Zymeworks in Q2 2019 and held it in 18 quarters.
  • Marathon Capital Management's Zymeworks position peaked at $2.24M in Q4 2019.
  • 171 funds tracked by Wall St. Rank held Zymeworks as of Q1 2024.

Based on Marathon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.